v3.24.1.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities    
Net loss $ (54,400) $ (24,815)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 4,470 3,750
Amortization of intangible assets 527 791
Change in fair value of 2022 USD Financing Warrants 32,893 5,185
Unrealized foreign exchange 514  
Other non-cash adjustments 75 14
Changes in operating assets and liabilities:    
Prepaid and other current assets 468 909
Other noncurrent assets 66 18
Accounts payable 1,509 209
Accrued expenses (2,703) 703
Other liabilities, long-term (17) (95)
Net cash used in operating activities (16,598) (13,331)
Cash flows from financing activities    
Proceeds from the Offering and Private Placement 175,000  
Payment of issuance costs from the Offering and Private Placement (8,720)  
Payment of credit facility issuance costs (128)  
Proceeds from the at-the-market offering program, net of issuance costs 984 583
Proceeds from exercise of warrants 1,700  
Proceeds from exercise of options 465  
Withholding taxes paid on vested RSUs (54)  
Net cash provided by financing activities 169,247 583
Effect of exchange rate changes on cash (21) 15
Net increase/(decrease) in cash and cash equivalents 152,628 (12,733)
Cash and cash equivalents, beginning of period 99,704 142,142
Cash and cash equivalents, end of period 252,332 $ 129,409
Supplemental Cash Flow Information    
Cash paid for interest 434  
Supplemental Noncash Disclosures    
Conversion of 2022 USD Financing Warrants to common shares upon exercise of warrants 1,669  
Unpaid issuance costs for the Offering and Private Placement 2,340  
Proceeds from exercise of options in prepaid and other current assets 65  
Reclass of deferred financing fees to additional paid-in capital $ 332  

Source

HTML PDF
ZIP